← Leaderboards
Sucheta Telang
University Of Louisville
$2,152,673
Attributed
$2,990,703
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $846.4K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,990,703 · 4
By mechanism
UG1$1,139,524 · 1
R01$1,050,767 · 1
R21$800,412 · 2
Top collaborators
- Lori Ann Devlin-Phinney4 shared
- Haixun Guo1 shared
- Nobuyuki Matoba1 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Jason A Chesney$5,360,168
- Yoannis Imbert-Fernandez$2,570,911
- Muriel C. Maurer$3,400,070
- Brian F Clem$1,327,981
- Bradford Guy Hill$9,840,515
Others in their field
Top investigators on “Family”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$221,216,149
- David R. Weir · University Of Michigan At Ann Arbor$166,939,143
- Richard A Gibbs · Baylor College Of Medicine$137,231,081
- Sharon A Nachman · Johns Hopkins University$135,132,510
- George R Seage · Abt Associates, Inc.$128,485,281
Research focus
FamilyDesignSiteImproved OutcomeTumorCellsClinically RelevantLung NeoplasmsTumor GrowthMalignant NeoplasmsIn VitroGlucose MetabolismGrowthGlycolysisHypoxiaFructoseGlucoseNeoplastic CellEvaluationIn VivoAttenuatedEnzymesEffective TherapyLung
Grant awards (12)
Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants$221,268
UG1 · FY2025 · HD
Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants$223,861
UG1 · FY2024 · HD
Antitumor potential of AvFc lectibody in non-small cell lung cancer$402,402
R21 · FY2023 · CA
Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants$228,911
UG1 · FY2023 · HD
Investigating the Role of PFKFB4 in the Immune Regulation of Lung Cancer$215,101
R21 · FY2023 · CA · contact PI
Investigating the Role of PFKFB4 in the Immune Regulation of Lung Cancer$182,909
R21 · FY2022 · CA · contact PI
Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants$465,484
UG1 · FY2021 · HD
Targeting Glucose Metabolism in Cancer$214,211
R01 · FY2013 · CA · contact PI
Targeting Glucose Metabolism in Cancer$227,884
R01 · FY2012 · CA · contact PI
Targeting Glucose Metabolism in Cancer$178,732
R01 · FY2011 · CA · contact PI
Targeting Glucose Metabolism in Cancer$184,260
R01 · FY2010 · CA · contact PI
Targeting Glucose Metabolism in Cancer$245,680
R01 · FY2009 · CA · contact PI